MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Longitudinal patterns of Anxiety and Depression in patients with Parkinson’s Disease

O. Lawal, M. Morales, S. Shakya, J. Savitt, S. Reich, A. Gruber-Baldini, L. Shulman, R. von Coelln (Baltimore, USA)

Meeting: 2024 International Congress

Abstract Number: 380

Keywords: Anxiety, Depression, Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To analyze longitudinal trends of severity of anxiety and depression in a large Parkinson’s Disease (PD) cohort

Background: •Depression and anxiety are common non motor symptoms in PD. The few published longitudinal studies on these symptoms in PD are limited by small sample size and brief follow-up. Patterns in severity of depression/ anxiety over longer time periods are unknown.

Method: 615 PD patients during sequential visits between 2014 and 2022. Anxiety and depression were measured using the Patient-Reported Outcome Measurement Information System (PROMIS-29)1. Based on T-scores, PD patients were categorized into 3 subgroups and at 2 and 4 years later.

T score < 55: No depression, no anxiety.

T score 55-60: Mild depression, mild anxiety.

T score > 60: Moderate to severe depression and anxiety.

Results: At baseline, 74% of patients had no depression, 16% mild, 10% moderate/severe; 69% had no anxiety, 16% mild, 15% moderate/severe. Over time, the proportion of patients without depression or anxiety decreased (2 years: depression 69%, anxiety 59%; 4 years: depression 64%, anxiety 55%), while the frequency of patients with some degree of depression or anxiety increased accordingly. For both depression and anxiety, most patients in the non-symptomatic (67-82%) and moderately/severely affected groups (55-64%) did not change category at follow-up. Patients with mild depression at baseline split evenly into all 3 categories after 2 years, with more shifting towards moderate/severe depression after 4 years. Likewise, the proportion of patients with mild anxiety that were re-categorized as moderate/severe anxiety increased from 24% after 2 years to 41% after 4 years.

Conclusion: The prevalence of both depression and anxiety in a large PD cohort increases over time. Most patients with either no or moderate/severe depression or anxiety remain in their baseline category. In contrast, patients with mild depression or anxiety at baseline show more variability in the severity of their mental health symptoms over time.

Fig 1 Trends of depression in PD

Fig 1 Trends of depression in PD

Fig 2 Trends of Anxiety in PD

Fig 2 Trends of Anxiety in PD

References: 1. Kroenke K, Stump TE, Chen CX, Kean J, Bair MJ, Damush TM, Krebs EE, Monahan PO. Minimally important differences and severity thresholds are estimated for the PROMIS depression scales from three randomized clinical trials. J Affect Disord. 2020 Apr

To cite this abstract in AMA style:

O. Lawal, M. Morales, S. Shakya, J. Savitt, S. Reich, A. Gruber-Baldini, L. Shulman, R. von Coelln. Longitudinal patterns of Anxiety and Depression in patients with Parkinson’s Disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/longitudinal-patterns-of-anxiety-and-depression-in-patients-with-parkinsons-disease/. Accessed July 6, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/longitudinal-patterns-of-anxiety-and-depression-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley